300093610064

The barcode 300093610064 is associated with the product SURFAK, which is a medication used as a surfactant replacement therapy specifically for neonates and preterm infants suffering from lung diseases. PHARMACIA AND UPJOHN, INC. is the manufacturer of this product.

SURFAK is primarily indicated for use in critically ill newborns and preterm infants who require mechanical ventilation or have primary pulmonary disease. It's important to recognize that while there are no specific warnings or concerns directly related to its active ingredients, like any medication, SURFAK can cause side effects, which may include:

• Respiratory issues
• Gastrointestinal problems
• Allergic reactions

Given the nature of the product, there exists a health-related disclaimer. The FDA advises that SURFAK is intended specifically for use in the indicated patient population.

Pricing for SURFAK can vary significantly across different regions and healthcare settings, but specific price information is not readily available.

Additionally, it is critical to adhere to the prescribed dosage instructions, as there is a potential for overdose with this medication. Always consult with a healthcare professional for proper guidance and management when using this product.